000 01502 a2200409 4500
005 20250516070405.0
264 0 _c20120217
008 201202s 0 0 eng d
022 _a1537-6613
024 7 _a10.1093/infdis/jir723
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiao, Guoyang
245 0 0 _aSafety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
_h[electronic resource]
260 _bThe Journal of infectious diseases
_cJan 2012
300 _a237-43 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aChi-Square Distribution
650 0 4 _aConfidence Intervals
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aPoliomyelitis
_ximmunology
650 0 4 _aPoliovirus
_ximmunology
650 0 4 _aPoliovirus Vaccine, Inactivated
_xadministration & dosage
650 0 4 _aPoliovirus Vaccine, Oral
_xadministration & dosage
700 1 _aLi, Rongcheng
700 1 _aLi, Changgui
700 1 _aSun, Mingbo
700 1 _aLi, Yanping
700 1 _aChu, Jiayou
700 1 _aJiang, Shude
700 1 _aLi, Qihan
773 0 _tThe Journal of infectious diseases
_gvol. 205
_gno. 2
_gp. 237-43
856 4 0 _uhttps://doi.org/10.1093/infdis/jir723
_zAvailable from publisher's website
999 _c21381673
_d21381673